Eric McDade
Impact in
- Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research
- Physiology top 0.1%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 93
- Physiology 82
- Alzheimer's disease research and treatments 80
- Co-authors
- Ronald Carl Petersen (8 shared papers)John H. Hollman (2 shared papers)Randall John Bateman (48 shared papers)Oscar L. López (21 shared papers)Clifford R. Jack (6 shared papers)William E. Klunk (20 shared papers)Beth Ellen Snitz (20 shared papers)Chester A. Mathis (16 shared papers)
- Journals
- Alzheimer s & Dementia (83 papers)Neurology (17 papers)Brain (10 papers)The Lancet Neurology (9 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (8 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Eric McDade
233 papers receiving 16.3k citations
Eric McDade's Hit Papers
Peers
Comparison fields: 5 of 174
- Psychiatry and Mental health 5.4k
- Physiology 6.3k
- Biological Psychiatry 524
- Neurology 1.8k
- Cognitive Neuroscience 2.2k
Countries citing papers authored by Eric McDade
This map shows the geographic impact of Eric McDade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric McDade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric McDade more than expected).
Fields of papers citing papers by Eric McDade
This network shows the impact of papers produced by Eric McDade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric McDade. The network helps show where Eric McDade may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric McDade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 242 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease Hit paper breakdown → | 2012 | 3086 |
| 2 | Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Hit paper breakdown → | 2024 | 1408 |
| 3 | Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease Hit paper breakdown → | 2019 | 715 |
| 4 | Normative spatiotemporal gait parameters in older adults Hit paper breakdown → | 2011 | 621 |
| 5 | A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease Hit paper breakdown → | 2020 | 502 |
| 6 | Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study Hit paper breakdown → | 2018 | 453 |
| 7 | White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network Hit paper breakdown → | 2016 | 443 |
| 8 | Symptom onset in autosomal dominant Alzheimer disease Hit paper breakdown → | 2014 | 406 |
| 9 | 2013 | 329 | |
| 10 | 2011 | 316 | |
| 11 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease Hit paper breakdown → | 2021 | 305 |
| 12 | 2019 | 270 | |
| 13 | 2016 | 249 | |
| 14 | 2018 | 248 | |
| 15 | Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study Hit paper breakdown → | 2022 | 228 |
| 16 | Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid Hit paper breakdown → | 2022 | 224 |
| 17 | 2017 | 206 | |
| 18 | 2011 | 197 | |
| 19 | 2012 | 183 | |
| 20 | 2011 | 166 |
About Eric McDade
Eric McDade is a scholar working on Psychiatry and Mental health, Physiology, Cognitive Neuroscience, Neurology and Statistics and Probability, having authored 242 papers that have together received 16.6k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (93 papers), Alzheimer's disease research and treatments (80 papers), Functional Brain Connectivity Studies (26 papers), Advanced Neuroimaging Techniques and Applications (12 papers), Statistical Methods in Clinical Trials (9 papers), Bioinformatics and Genomic Networks (9 papers), Down syndrome and intellectual disability research (7 papers) and Intracerebral and Subarachnoid Hemorrhage Research (6 papers). The work is most often cited by research in Psychiatry and Mental health (5.4k citations), Physiology (6.3k citations), Biological Psychiatry (524 citations), Neurology (1.8k citations) and Cognitive Neuroscience (2.2k citations). Eric McDade has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ronald Carl Petersen, John H. Hollman, Randall John Bateman, Oscar L. López, Clifford R. Jack, William E. Klunk, Beth Ellen Snitz, Chester A. Mathis, Ann D. Cohen and Julie C. Price. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Brain, The Lancet Neurology and Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.